Using the ResCu system for preclinical testing of KRAS G12C inhibitors

被引：0
|
作者：
Ruiz, Victor M. [1 ]
Hill, Lindsay [1 ]
Gadde, Manasa [1 ]
Bulow, Christopher [1 ]
Morri, Maurizio [1 ]
Goldner, Nicholas [1 ]
机构：
[1] ResistanceBio, San Carlos, CA USA
来源：
MOLECULAR CANCER RESEARCH | 2023年 / 21卷 / 05期
关键词：
D O I：
10.1158/1557-3125.RAS23-B030
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
B030
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Targeting KRAS G12C with Covalent Inhibitors
    Ostrem, Jonathan M. L.
    Shokat, Kevan M.
    ANNUAL REVIEW OF CANCER BIOLOGY, 2022, 6 : 49 - 64
  • [2] Mechanisms of Resistance to KRAS G12C Inhibitors
    Ambrogio, C.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S96 - S96
  • [3] Clinical Data for KRAS G12C Inhibitors
    Kim, H. R.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S95 - S96
  • [4] The promise and peril of KRAS G12C inhibitors
    Moore, Amanda R.
    Malek, Shiva
    CANCER CELL, 2021, 39 (08) : 1059 - 1061
  • [5] Establishment of KRAS G12C mutant brain metastasis models for preclinical evaluation of KRAS G12C targeted anticancer therapy
    Chen, Qikuan
    Wang, Guilan
    Yin, Yingfei
    CANCER RESEARCH, 2024, 84 (06)
  • [6] Development of inhibitors of the activated form of KRAS G12C
    Pollock, R.
    Stewart, M.
    Perl, N.
    Lee, S. J.
    Xue, L.
    Zhou, M.
    Simon, J.
    Luly, K.
    Grigoriu, S.
    Yuzhakov, A.
    Silver, A.
    Lowe, J.
    Mann, A.
    Verdine, G.
    Rigby, A.
    Mulvihill, M.
    May, E.
    Kohlmann, A.
    Townson, S.
    Jin, M.
    EUROPEAN JOURNAL OF CANCER, 2018, 103 : E52 - E52
  • [7] Covalent Guanosine Mimetic Inhibitors of G12C KRAS
    Xiong, Yuan
    Lu, Jia
    Hunter, John
    Li, Lianbo
    Scott, David
    Choi, Hwan Geun
    Lim, Sang Min
    Manandhar, Anuj
    Gondi, Sudershan
    Sim, Taebo
    Westover, Kenneth D.
    Gray, Nathanael S.
    ACS MEDICINAL CHEMISTRY LETTERS, 2017, 8 (01): : 61 - 66
  • [8] Overcoming adaptive resistance to KRAS G12C inhibitors
    Adachi, Yuta
    Niitsu, Hiroaki
    Yamaguchi, Rui
    Ebi, Hiromichi
    CANCER SCIENCE, 2024, 115 : 110 - 110
  • [9] Optimization of intermittent dosing strategies of KRAS G12C inhibitors in preclinical lung cancer model
    Navarro, Valeria Estrada
    Panneton, Vincent
    Dong, Lauren
    Choi, Hyejin
    Venkatesh, Divya
    Maniyar, Rachana
    Schulze, Isabell
    Wolchok, Jedd D.
    Merghoub, Taha
    CANCER RESEARCH, 2024, 84 (06)
  • [10] Oncogenic non-G12C KRAS mutations in KRAS G12C mutated lung adenocarcinomas in TRACERx and GENIE: A reservoir for intrinsic resistance to KRAS G12C inhibitors
    Marinelli, D.
    Pisegna, S.
    Giammaruco, M.
    Chesi, P.
    Mammone, G.
    Ceddia, S.
    Gazzaniga, P.
    Cortesi, E.
    Gelibter, A. J.
    ANNALS OF ONCOLOGY, 2021, 32 : S1345 - S1346
12345